Biomarkers for Chronic Pancreatitis: From Diagnosis to Treatment

Abstract

Chronic pancreatitis (CP) is a progressive inflammatory disorder of the pancreas,

characterized by irreversible damage to pancreatic tissue and loss of function. Despite

advancements in our understanding of CP, accurate diagnosis and effective treatment remain

challenging. Recent developments in biomarker research have paved the way for improved

diagnosis, better prognostication, and more targeted therapies. This paper reviews the current

state of biomarkers for chronic pancreatitis, highlighting their role in disease diagnosis,

prognosis, and therapeutic decision-making. Various categories of biomarkers, including

serum markers, genetic markers, imaging biomarkers, and novel molecular biomarkers, are

discussed. Future research directions and the potential for personalized treatment strategies

are also considered.